Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.850
-0.020 (-1.07%)
Feb 27, 2026, 9:39 AM EST - Market open

Ocugen Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
607235147285906297
Market Cap Growth
209.21%59.00%-48.17%-68.60%205.66%983.53%
Enterprise Value
614203100189802288
Last Close Price
1.870.810.571.304.551.83
Forward PE
----52.48-
PS Ratio
114.1857.8324.44114.37-6895.55
PB Ratio
165.317.913.643.859.4613.76
P/TBV Ratio
173.557.913.643.859.4613.76
EV/Sales Ratio
114.2649.9616.6576.14-6695.34
Debt / Equity Ratio
9.331.100.170.090.040.12
Net Debt / Equity Ratio
0.11-0.88-0.80-1.14-0.96-1.00
Net Debt / EBITDA Ratio
-0.010.490.500.951.591.52
Net Debt / FCF Ratio
-0.010.570.451.311.871.44
Asset Turnover
0.090.060.070.02-0.00
Quick Ratio
1.602.712.313.1913.576.65
Current Ratio
1.852.862.523.4514.667.16
Return on Equity (ROE)
-289.93%-154.01%-110.14%-102.24%-99.46%-134.01%
Return on Assets (ROA)
-63.67%-46.56%-47.30%-51.93%-54.48%-40.41%
Return on Capital Employed (ROCE)
-163.50%-90.00%-138.10%-111.20%-58.80%-60.10%
Earnings Yield
-10.44%-23.05%-42.77%-30.50%-6.44%-7.36%
FCF Yield
-8.73%-19.41%-49.18%-22.68%-5.41%-5.06%
Buyback Yield / Dilution
-12.36%-10.91%-13.85%-10.04%-73.75%-707.81%
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q